FDA announces recall of thyroid medication
The FDA announced the recall for thyroid medication because it may have ingredients with deficiencies that may introduce risks to users.
On Aug. 9, Westminster Pharmaceuticals issued the recall all lots of Levothyroxine and Liothyronine thyroid tablets in dosages of 15 mg, 30 mg, 60 mg, 90 mg, & 120 mg.
Ingredients were sourced prior to the FDA’s Import Alert of Sichuan Friendly Pharmaceutical, found to have deficiencies of manufacturing processes.
Currently Westminster Pharmaceuticals has not received any reports of adverse events related to this product.
The tablets, taken orally, are indicated as replacement or supplemental therapy in patients with hypothyroidism.
The recall said:
"Because these products may be used in the treatment of serious medical conditions, patients taking the recalled medicines should continue taking their medicine until they have a replacement product.
"The products subject to recall are packed in 100-count bottles. To best identify the product the NDC’s, Product Description, Lot numbers and Expiration dates are listed below. These lots were distributed nationwide in the USA to Westminster’s direct accounts."
According to the recall, Westminster is notifying its direct accounts by email and by phone to immediately discontinue distribution of the product under recall.
For more information visit: fda.gov/Safety/Recalls/ucm616601.htm